Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients
Status:
Terminated
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This study, a nonrandomized open-label Phase I safety and exploratory study, will evaluate
the safety of topical norepinephrine in post-surgical breast cancer patients who are
undergoing radiation therapy.
The study will also provide information about whether topical norepinephrine can prevent or
decrease the severity of the radiation dermatitis experienced by these patients.